CAT and Alzheimer disease: These findings suggest that MSCs protect against AD through three complementary mechanisms: (1) the internalization and degradation of AβOs, (2) the release of EVs containing active catalase, and (3) the selective secretion of anti-inflammatory cytokines and neurotrophic factors (Gatti et al., 2020).